Characterization of Decay-Accelerating Factor (DAF) in Human Skin
Authors:
- Satoshi ShiraishiSSSatoshi Shiraishi
- Yuji ShirakataYSYuji Shirakata
- Yuko KobayashiYKYuko Kobayashi
- Yoshiharu MikiYMYoshiharu Miki
- 1 January 1991
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 96 (1) , 61-64
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Deposition of the Membrane Attack Complex of Complement in Pemphigus Vulgaris and Pemphigus Foliaceus SkinJournal of Investigative Dermatology, 1989
- Decay-accelerating Factor in Human Skin Is Associated with Elastic FibersJournal of Investigative Dermatology, 1988
- Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.Journal of Experimental Medicine, 1987
- Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipidBiochemistry, 1986
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.Journal of Experimental Medicine, 1986
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.Journal of Experimental Medicine, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.Journal of Experimental Medicine, 1984
- Deposition of the Membrane Attack Complex of Complement in Bullous PemphigoidJournal of Investigative Dermatology, 1984
- Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.Proceedings of the National Academy of Sciences, 1983
- Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.The Journal of Immunology, 1982